[Clinical trial of a new tranquilizing agent: trioxazine].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001007:Anxiety / Q000188:drug therapy*; D003863:Depression / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006998:Hypochondriasis / Q000188:drug therapy*; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D009025:Morpholines; D014149:Tranquilizing Agents
Sperimentazione clinica di un nuovo tranquillante: la trioxazina.